Clinical Trial Update: A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated MEHD7945A in combination with cisplatin/5-FU or paclitaxel/carboplatin in patients with recurrent/metastatic head and nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 5-FU (5-fluorouracil)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• MEHD7945A (MEHD7945A)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Genentech, Inc. | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED